Date | Time | Source | Headline | Symbol | Company |
05/15/2024 | 2:30PM | iHub Newswire | FeaturedIntegrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share | | |
08/02/2010 | 3:20AM | Dow Jones News | Philips Buys Health Business In Israel, No Financial Details | NASDAQ:MEDI | Medtechnica Ltd. |
06/18/2007 | 5:37PM | PR Newswire (US) | MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv | NASDAQ:MEDI | |
06/12/2007 | 2:00PM | PR Newswire (US) | MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM) | NASDAQ:MEDI | |
05/25/2007 | 6:00PM | PR Newswire (US) | MedImmune Receives Correspondence From FDA Regarding FluMist(R) | NASDAQ:MEDI | Medimmune (MM) |
05/24/2007 | 12:30PM | PR Newswire (US) | MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations | NASDAQ:MEDI | Medimmune (MM) |
05/24/2007 | 12:30PM | PR Newswire (US) | Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting | NASDAQ:MEDI | Medimmune (MM) |
05/16/2007 | 4:17PM | PR Newswire (US) | FDA Advisory Committee Recommends Expanded Use of FluMist(R) | NASDAQ:MEDI | Medimmune (MM) |
05/08/2007 | 3:30PM | PR Newswire (US) | Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings | NASDAQ:MEDI | Medimmune (MM) |
05/08/2007 | 1:01PM | PR Newswire (US) | MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:25AM | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:14AM | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:05AM | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:00AM | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:00AM | PR Newswire (US) | MedImmune Provides Fellowship Grants to Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 11:00AM | PR Newswire (US) | MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers | NASDAQ:MEDI | Medimmune (MM) |
05/07/2007 | 10:30AM | PR Newswire (US) | MedImmune and Pediatric Infectious Diseases Society Present 2007 Career Development Award and Viral Respiratory Disease Fellowsh | NASDAQ:MEDI | Medimmune (MM) |
05/02/2007 | 4:31PM | PR Newswire (US) | MedImmune, Inc. Announces Convertibility of 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 201 | NASDAQ:MEDI | Medimmune (MM) |
05/02/2007 | 9:15AM | PR Newswire (US) | Pediatric Academic Societies' Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, | NASDAQ:MEDI | Medimmune (MM) |
04/30/2007 | 6:30PM | PR Newswire (US) | MedImmune Reports Financial Results for 2007 First Quarter | NASDAQ:MEDI | Medimmune (MM) |
04/19/2007 | 8:30AM | PR Newswire (US) | MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE(R) Molecule | NASDAQ:MEDI | Medimmune (MM) |
04/18/2007 | 5:00PM | PR Newswire (US) | MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases | NASDAQ:MEDI | Medimmune (MM) |
04/18/2007 | 1:05PM | PR Newswire (US) | Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA | NASDAQ:MEDI | Medimmune (MM) |
04/16/2007 | 10:45AM | PR Newswire (US) | Icahn Comments on MedImmune Sale Process | NASDAQ:MEDI | Medimmune (MM) |
04/12/2007 | 9:38AM | PR Newswire (US) | MedImmune Explores Strategic Alternatives | NASDAQ:MEDI | Medimmune (MM) |
04/09/2007 | 9:00AM | PR Newswire (US) | MedImmune Announces Preliminary Results for 2007 First Quarter | NASDAQ:MEDI | Medimmune (MM) |
04/02/2007 | 9:30AM | PR Newswire (US) | MedImmune Promotes Three Leaders in Key Scientific & Medical Roles | NASDAQ:MEDI | Medimmune (MM) |
04/02/2007 | 9:15AM | PR Newswire (US) | MedImmune Announces Addition of Robert H. Hotz To Board of Directors | NASDAQ:MEDI | Medimmune (MM) |
03/30/2007 | 10:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on MO, HAL, S, MEDI, and ETFC | NASDAQ:MEDI | Medimmune (MM) |
03/29/2007 | 11:45AM | PR Newswire (US) | MedImmune Licenses Reverse Genetics Technology to sanofi pasteur for Use in Influenza Vaccine Production | NASDAQ:MEDI | Medimmune (MM) |